Skip to main content
logo
Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
4.540
-0.240 (-5.02%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.24.95.174.535.514.47
Revenue Growth
10.70%-5.22%14.24%-17.77%23.11%443.62%
Gross Profit
5.24.95.174.535.514.47
Operating Income
-37.23-36.63-42.44-40.89-36.95-23.82
Net Income
-16.3-173.8-18.92-69.05-36.92-23.16
Earnings Per Share
-7.77-4.80-0.52-1.91-1.08-0.96
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.758.699.2913.5214.8510.29
Total Debt
373.67288.02126.52120.3748.8237.99
Net Cash (Debt)
-368.92-279.33-117.22-106.85-33.96-27.7
Net Cash Growth
------
Net Cash Per Share
-10.16-7.71-3.24-2.96-0.99-1.15

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-23.97-25.76-37.55-47.42-32.48-23.58
Capital Expenditures
-0.51-0.54-1.88-8.14-2.21-1.3
Free Cash Flow
-24.47-26.31-39.43-55.57-34.69-24.88
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-715.65%-747.02%-820.18%-902.85%-670.77%-532.45%
Pretax Margin
-5432.80%-3544.03%-365.60%-1524.51%-670.24%-517.55%
Profit Margin
-313.25%-3544.03%-365.60%-1524.51%-670.24%-517.55%
FCF Margin
-470.42%-536.40%-762.08%-1226.92%-629.85%-556.08%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
32.0446.6512.9425.848.1433.21